Insiders who reported open-market trades in the last 12 months at the companies Eric Warren files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Eric Warren is a corporate insider, tracked as Chief Commercial Officer of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Eric Warren submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Eric Warren been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($3.30M) across all tracked filings.
Eric Warren is Chief Commercial Officer of Mineralys Therapeutics, Inc. (MLYS). 7 SEC Form 4 filings on record going back to 2024, most recently on 22 September 2026. Most recent open-market trade: sold $209K of MLYS on 22 September 2026. Lifetime open-market sales: $3.30M.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Eric Warren.
InsiderAlpha's records for Eric Warren go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. 12 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
